Literature DB >> 8530065

Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction.

D J Day1, P W Speiser, P C White, F Barany.   

Abstract

Steroid 21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia, an inherited inability to synthesize cortisol that occurs in 1 in 10,000-15,000 births. Affected females are born with ambiguous genitalia, a condition that can be ameliorated by administering dexamethasone to the mother for most of gestation. Prenatal diagnosis is required for accurate treatment of affected females as well as for genetic counseling purposes. Approximately 95% of mutations causing this disorder result from recombinations between the gene encoding the 21-hydroxylase enzyme (CYP21) and a linked, highly homologous pseudogene (CYP21P). Approximately 20% of these mutations are gene deletions, and the remainder are gene conversions that transfer any of nine deleterious mutations from the CYP21P pseudogene to CYP21. We describe a methodology for genetic diagnosis of 21-hydroxylase deficiency that utilizes gene-specific PCR amplification in conjunction with thermostable DNA ligase to discriminate single nucleotide variations in a multiplexed ligation detection assay. The assay has been designed to be used with either fluorescent or radioactive detection of ligation products by electrophoresis on denaturing acrylamide gels and is readily adaptable for use in other disease systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530065     DOI: 10.1006/geno.1995.1226

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  22 in total

Review 1.  An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.

Authors:  C E Keegan; A A Killeen
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

2.  Analysis of CYP21 coding polymorphisms in three ethnic populations: further evidence of nonamplifying CYP21 alleles among whites.

Authors:  I C Ozturk; W L Wei; L Palaniappan; M Rubenfire; A A Killeen
Journal:  Mol Diagn       Date:  2000-03

Review 3.  The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency.

Authors:  Hsien-Hsiung Lee
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

4.  Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Gabriela P Finkielstain; Wuyan Chen; Sneha P Mehta; Frank K Fujimura; Reem M Hanna; Carol Van Ryzin; Nazli B McDonnell; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

5.  Improving the fidelity of Thermus thermophilus DNA ligase.

Authors:  J Luo; D E Bergstrom; F Barany
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

6.  Single-well genotyping of diallelic sequence variations by a two-color ELISA-based oligonucleotide ligation assay.

Authors:  V O Tobe; S L Taylor; D A Nickerson
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

7.  Ligation reaction specificities of an NAD(+)-dependent DNA ligase from the hyperthermophile Aquifex aeolicus.

Authors:  J Tong; F Barany; W Cao
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

8.  PCR/LDR/universal array platforms for the diagnosis of infectious disease.

Authors:  Maneesh Pingle; Mark Rundell; Sanchita Das; Linnie M Golightly; Francis Barany
Journal:  Methods Mol Biol       Date:  2010

9.  Ligase detection reaction for the analysis of point mutations using free-solution conjugate electrophoresis in a polymer microfluidic device.

Authors:  Rondedrick Sinville; Jennifer Coyne; Robert J Meagher; Yu-Wei Cheng; Francis Barany; Annelise Barron; Steven A Soper
Journal:  Electrophoresis       Date:  2008-12       Impact factor: 3.535

10.  Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.

Authors:  Yongtaek Oh; Sung Won Park; Sung-Min Chun; Namkyoo Lim; Ki Sup Ahn; Jong-Ok Ka; Dong-Kyu Jin; Byoung-Don Han
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.